References
- Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed M, et al. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993;87:1776-80. https://doi.org/10.1161/01.CIR.87.5.1776
- Rowley AH, Shulman ST. Kawasaki syndrome. Pediatr Clin North Am 1999;46:313-29. https://doi.org/10.1016/S0031-3955(05)70120-6
- Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991;324:1149-55. https://doi.org/10.1056/NEJM199104253241701
- Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet 1999;354:407-13. https://doi.org/10.1016/S0140-6736(98)11058-9
- Hofmann MA, Lalla E, Lu Y, Gleason MR, Wolf BM, Tanji N, et al. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest 2001;107:675-83. https://doi.org/10.1172/JCI10588
- Kawashiri M, Kajinami K, Nohara A, Yagi K, Inazu A, Koizumi J, et al. Plasma homocysteine level and development of coronary artery disease. Coron Artery Dis 1999;10:443-7. https://doi.org/10.1097/00019501-199910000-00002
- Sadeghian S, Fallahi F, Salarifar M, Davoodi G, Mahmoodian M, Fallah N, et al. Homocysteine, vitamin B12 and folate levels in premature coronary artery disease. BMC Cardiovasc Disord 2006;6:38. https://doi.org/10.1186/1471-2261-6-38
- Noto N, Okada T, Karasawa K, Ayusawa M, Sumitomo N, Harada K, et al. Age-related acceleration of endothelial dysfunction and subclinical atherosclerosis in subjects with coronary artery lesions after Kawasaki disease. Pediatr Cardiol 2009;30:262-8.
- Ghelani SJ, Singh S, Manojkumar R. Endothelial dysfunction in a cohort of North Indian children with Kawasaki disease without overt coronary artery involvement. J Cardiol 2009;53:226-31. https://doi.org/10.1016/j.jjcc.2008.11.006
- Takahashi M. The endothelium in Kawasaki disease: the next frontier. J Pediatr 1998;133:177-9. https://doi.org/10.1016/S0022-3476(98)70216-1
- Morita H, Taguchi J, Kurihara H, Kitaoka M, Kaneda H, Kurihara Y, et al. Genetic polymorphism of 5, 10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 1997; 95:2032-6. https://doi.org/10.1161/01.CIR.95.8.2032
-
Pinto X, Vilaseca MA, Garcia-Giralt N, Ferrer I, Palá M, Meco JF, et al. Homocysteine and the MTHFR 677C
$\rightarrow$ T allele in premature coonary artery disease. Case control and family studies. Eur J Clin Invest 2001;31:24-30. https://doi.org/10.1046/j.1365-2362.2001.00760.x - Tsukahara H, Hiraoka M, Saito M, Nishida K, Kobata R, Tsuchida S, et al. Methylenetetrahydrofolate reductase polymorphism in Kawasaki disease. Pediatr Int 2000;42:236-40. https://doi.org/10.1046/j.1442-200x.2000.01229.x
- Kluijtmans LA, van den Heuvel LP, Boers GH, Frosst P, Stevens EM, van Oost BA, et al. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996; 58:35-41.
-
Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG; MTHFR Studies Collaboration Group. MTHFR 677C
$\rightarrow$ T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 2002;288:2023-31. https://doi.org/10.1001/jama.288.16.2023 - van Bockxmeer FM, Mamotte CD, Vasikaran SD, Taylor RR. Methylenetetrahydrofolate reductase gene and coronary artery disease. Circulation 1997;95:21-3. https://doi.org/10.1161/01.CIR.95.1.21
- Schwartz SM, Siscovick DS, Malinow MR, Rosendaal FR, Beverly RK, Hess DL, et al. Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene. Circulation 1997;96:412-7. https://doi.org/10.1161/01.CIR.96.2.412
- Martin YN, Salavaggione OE, Eckloff BW, Wieben ED, Schaid DJ, Weinshilboum RM. Human methylenetetrahydrofolate reductase pharmacogenomics: gene resequencing and functional genomics. Pharmacogenet Genomics 2006;16:265-77 https://doi.org/10.1097/01.fpc.0000194423.20393.08
- Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ, et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 2008;40: 827-34. https://doi.org/10.1038/ng.171
- Palomino-Morales R, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Rodriguez L, Miranda-Filloy JA, Fernandez-Gutierrez B, et al. A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis. Arthritis Res Ther 2010;12:R71. https://doi.org/10.1186/ar2989
Cited by
- MTHFR rs2274976 polymorphism is a risk marker for nonsyndromic cleft lip with or without cleft palate in the Brazilian population vol.100, pp.1, 2011, https://doi.org/10.1002/bdra.23199
- The association of methylene tetrahydrofolate reductase (MTHFR) A1298C gene polymorphism, homocysteine, vitamin B12, and folate with coronary artery disease (CAD) in the north of Iran vol.45, pp.6, 2011, https://doi.org/10.1515/tjb-2019-0340